• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估 EQ-5D 与疾病特异性效用测量的内容。

Evaluation of content on EQ-5D as compared to disease-specific utility measures.

机构信息

Center for Pharmacoeconomic Research and Department of Pharmacy Practice and Pharmacy Administration, University of Illinois at Chicago, 833 South Wood St., Room 164, M/C 886, Chicago, IL 60612, USA.

出版信息

Qual Life Res. 2013 May;22(4):853-74. doi: 10.1007/s11136-012-0207-6. Epub 2012 Jun 23.

DOI:10.1007/s11136-012-0207-6
PMID:22729670
Abstract

PURPOSE

The goal of this study was to appraise the extent of unique content on disease-specific preference-based measures (DSPMs) when contrasted with the EQ-5D using published studies and to inform whether EQ-5D could be inadequate as a utility measure in its content coverage for a given disease-specific application.

METHODS

A structured search of published literature was performed using PubMed and EMBASE/Medline database from Jan 1, 1990 to Mar 31, 2011. Articles were eligible for inclusion if algorithms were developed to convert components from disease-specific measures into utility scores.

RESULTS

Of 1,029 articles identified, 50 studies satisfied the inclusion criteria. The most frequent conditions where DSPMs were developed included cancer (12 studies), coronary artery disease (4 studies), osteoarthritis, rheumatoid arthritis (3 studies of each), obesity, and stroke (2 studies of each). Most studies involved mapping items or scores from disease-specific non-preference-based measures onto a preference-based measure of health such as the EQ-5D. A substantial number of DSPMs appeared to include unique content not covered by EQ-5D dimensions.

CONCLUSIONS

Several conditions were identified as potential areas where the richness of the EQ-5D descriptive system could be enhanced. It is yet unclear whether added dimension(s) would contribute unique explained variance to a utility score. Given the resources required to rigorously develop a utility measure, the need for such measures should be carefully vetted.

摘要

目的

本研究旨在通过已发表的研究评估特定疾病偏好性测量(DSPM)与 EQ-5D 相比时其特有内容的程度,并探讨 EQ-5D 在特定疾病应用中是否可能因其涵盖的内容不足而无法作为效用测量。

方法

使用 PubMed 和 EMBASE/Medline 数据库,从 1990 年 1 月 1 日至 2011 年 3 月 31 日进行了已发表文献的结构化搜索。只有在开发了算法将疾病特异性测量的组成部分转换为效用评分的情况下,文章才符合纳入标准。

结果

在确定的 1029 篇文章中,有 50 项研究符合纳入标准。开发 DSPM 的最常见疾病包括癌症(12 项研究)、冠状动脉疾病(4 项研究)、骨关节炎、类风湿关节炎(各 3 项研究)、肥胖症和中风(各 2 项研究)。大多数研究涉及将疾病特异性非偏好性测量的项目或分数映射到健康偏好性测量,如 EQ-5D。许多 DSPM 似乎包含 EQ-5D 维度未涵盖的特有内容。

结论

确定了一些可能需要增强 EQ-5D 描述性系统丰富性的疾病领域。目前尚不清楚增加的维度是否会对效用评分产生独特的解释方差。鉴于开发效用测量所需的资源,需要仔细审查此类测量的必要性。

相似文献

1
Evaluation of content on EQ-5D as compared to disease-specific utility measures.评估 EQ-5D 与疾病特异性效用测量的内容。
Qual Life Res. 2013 May;22(4):853-74. doi: 10.1007/s11136-012-0207-6. Epub 2012 Jun 23.
2
Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement.回顾和评价将生活质量或临床指标映射到 EQ-5D 的研究:一个在线数据库和 MAPS 声明的应用。
Health Qual Life Outcomes. 2018 Feb 12;16(1):31. doi: 10.1186/s12955-018-0857-3.
3
Comparison of FACT- and EQ-5D-based utility scores in cancer.癌症患者 FACT 和 EQ-5D 量表效用评分的比较。
Value Health. 2012 Mar-Apr;15(2):305-11. doi: 10.1016/j.jval.2011.11.029. Epub 2012 Feb 2.
4
A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.类风湿关节炎患者使用 EQ-5D 和 SF-6D 偏好型通用量表进行效用测量的比较。
Clin Exp Rheumatol. 2011 Jul-Aug;29(4):661-71. Epub 2011 Aug 31.
5
Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice.估算基于偏好的通用效用量表与严重慢性便秘特定疾病生命质量测量指标之间的关系:实践中的挑战。
Pharmacoeconomics. 2011 Aug;29(8):719-30. doi: 10.2165/11588360-000000000-00000.
6
Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA database.日本类风湿性关节炎患者日常实践中EQ-5D效用评分概况;IORRA数据库分析
Mod Rheumatol. 2016;26(1):40-5. doi: 10.3109/14397595.2015.1059983. Epub 2015 Jul 20.
7
Can Mapping Algorithms Based on Raw Scores Overestimate QALYs Gained by Treatment? A Comparison of Mappings Between the Roland-Morris Disability Questionnaire and the EQ-5D-3L Based on Raw and Differenced Score Data.基于原始分数的映射算法会高估治疗所获得的质量调整生命年吗?基于原始分数和差分分数数据对罗兰-莫里斯残疾问卷与EQ-5D-3L之间映射的比较。
Pharmacoeconomics. 2017 May;35(5):549-559. doi: 10.1007/s40273-016-0483-z.
8
'Mapping' Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases.从非偏好性测量指标映射健康状态效用值:罕见病的系统文献回顾。
Pharmacoeconomics. 2020 Jun;38(6):557-574. doi: 10.1007/s40273-020-00897-4.
9
Health-Related Quality of Life and Functional Ability of Patients with Rheumatoid Arthritis: A Study from a Tertiary Care Hospital in Thailand.类风湿关节炎患者的健康相关生活质量和功能能力:来自泰国一家三级护理医院的研究。
Value Health Reg Issues. 2018 May;15:76-81. doi: 10.1016/j.vhri.2017.08.012. Epub 2017 Oct 16.
10
Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.将SRS-22r问卷映射到青少年特发性脊柱侧凸患者的EQ-5D-5L效用评分上。
PLoS One. 2017 Apr 17;12(4):e0175847. doi: 10.1371/journal.pone.0175847. eCollection 2017.

引用本文的文献

1
Norwegian and Swedish value sets for the EORTC QLU-C10D utility instrument.欧洲癌症研究与治疗组织生活质量核心问卷-10维度效用工具的挪威和瑞典价值集。
Qual Life Res. 2025 Feb;34(2):429-443. doi: 10.1007/s11136-024-03824-8. Epub 2024 Nov 5.
2
Estimation of Health State Utility Values for Immunoglobulin A Nephropathy: A Time Trade-Off Analysis.免疫球蛋白A肾病健康状态效用值的评估:一项时间权衡分析。
Pharmacoecon Open. 2025 Jan;9(1):83-92. doi: 10.1007/s41669-024-00527-1. Epub 2024 Sep 21.
3
Appropriateness of the EQ-5D-5L in capturing health-related quality of life in individuals with transfusion-dependent β-thalassemia: a mixed methods study.

本文引用的文献

1
Development of the EXACT-U: a preference-based measure to report COPD exacerbation utilities.EXACT-U 的制定:一种基于偏好的报告 COPD 加重效用的测量方法。
Value Health. 2011 Jun;14(4):546-54. doi: 10.1016/j.jval.2010.10.032. Epub 2011 May 19.
2
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).新的 EQ-5D 五维版本(EQ-5D-5L)的制定和初步测试。
Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.
3
Predicting health-utility scores from the Cervical Spine Outcomes Questionnaire in a multicenter nationwide study of anterior cervical spine surgery.
用于评估输血依赖型β-地中海贫血患者健康相关生活质量的 EQ-5D-5L 的适宜性:一项混合方法研究。
Health Qual Life Outcomes. 2024 Jul 11;22(1):54. doi: 10.1186/s12955-024-02265-8.
4
A scoping review to create a framework for the steps in developing condition-specific preference-based instruments de novo or from an existing non-preference-based instrument: use of item response theory or Rasch analysis.一项范围综述,旨在为从头开发或从现有非偏好量表中开发特定疾病偏好量表的步骤创建一个框架:使用项目反应理论或 Rasch 分析。
Health Qual Life Outcomes. 2024 May 14;22(1):38. doi: 10.1186/s12955-024-02253-y.
5
Danish value sets for the EORTC QLU-C10D utility instrument.丹麦 EORTC QLU-C10D 效用量表值。
Qual Life Res. 2024 Mar;33(3):831-841. doi: 10.1007/s11136-023-03569-w. Epub 2024 Jan 6.
6
Sensitivity of the EQ-5D-5L for fatigue and cognitive problems and their added value in Q-fever patients.EQ-5D-5L 量表对疲劳和认知问题的敏感性及其在 Q 热患者中的附加价值。
Qual Life Res. 2022 Jul;31(7):2083-2092. doi: 10.1007/s11136-021-03069-9. Epub 2022 Jan 29.
7
Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms.使基于偏好的效用测量适应于捕捉癌症治疗相关症状的影响。
Eur J Health Econ. 2021 Nov;22(8):1301-1309. doi: 10.1007/s10198-021-01337-6. Epub 2021 Jun 17.
8
Development of one general and six country-specific algorithms to assess societal health utilities based on ASAS HI.开发一种通用算法和六种特定国家算法,基于 ASAS HI 评估社会健康效用。
RMD Open. 2019 May 21;5(1):e000872. doi: 10.1136/rmdopen-2018-000872. eCollection 2019.
9
The added value of the EQ-5D with a cognition dimension in injury patients with and without traumatic brain injury.EQ-5D 认知维度在伴有和不伴有创伤性脑损伤的损伤患者中的附加价值。
Qual Life Res. 2019 Jul;28(7):1931-1939. doi: 10.1007/s11136-019-02144-6. Epub 2019 Feb 28.
10
Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement.回顾和评价将生活质量或临床指标映射到 EQ-5D 的研究:一个在线数据库和 MAPS 声明的应用。
Health Qual Life Outcomes. 2018 Feb 12;16(1):31. doi: 10.1186/s12955-018-0857-3.
在一项多中心全国性的前路颈椎手术研究中,从颈椎结局问卷预测健康效用评分。
Spine (Phila Pa 1976). 2011 Dec 1;36(25):2211-6. doi: 10.1097/BRS.0b013e318202a403.
4
Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain.采用 HAQ-DI 估算西班牙类风湿关节炎患者的 HUI-3 和 EQ-5D 效用值。
Value Health. 2011 Jan;14(1):192-200. doi: 10.1016/j.jval.2010.11.001.
5
Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancer.从欧洲癌症研究与治疗组织生活质量核心 30 问卷值推导肺癌的效用值。
J Thorac Oncol. 2010 Dec;5(12):1953-7. doi: 10.1097/jto.0b013e3181f77a6a.
6
Predicting EQ-5D utility scores from the Seattle Angina Questionnaire in coronary artery disease: a mapping algorithm using a Bayesian framework.基于贝叶斯框架的映射算法:从冠状动脉疾病西雅图心绞痛问卷预测 EQ-5D 效用评分。
Med Decis Making. 2011 May-Jun;31(3):481-93. doi: 10.1177/0272989X10386800. Epub 2010 Dec 2.
7
A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis.比较轻度至中度活动溃疡性结肠炎中医生评估的疾病严重程度和患者报告的结果。
J Crohns Colitis. 2010 Sep;4(3):275-82. doi: 10.1016/j.crohns.2009.11.010. Epub 2009 Dec 10.
8
Mapping utility scores from a disease-specific quality-of-life measure in bariatric surgery patients.将特定于疾病的生活质量测量在减重手术患者中的效用评分进行映射。
Value Health. 2009 Mar-Apr;12(2):364-70. doi: 10.1111/j.1524-4733.2008.00442.x.
9
Use of a disease-specific instrument in economic evaluations: mapping WOMAC onto the EQ-5D utility index.使用特定疾病的工具进行经济评估:将 WOMAC 映射到 EQ-5D 效用指数上。
Value Health. 2010 Dec;13(8):873-8. doi: 10.1111/j.1524-4733.2010.00770.x.
10
Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis.类风湿关节炎患者的 US EQ-5D、UK EQ-5D 和 SF-6D 的量表特征和映射准确性。
J Rheumatol. 2010 Aug 1;37(8):1615-25. doi: 10.3899/jrheum.100043. Epub 2010 Jun 15.